Consequences of obstructive sleep apnea: cardiovascular risk of obstructive sleep apnea and whether continuous positive airway pressure reduces that risk

R Khayat, A Pleister - Sleep medicine clinics, 2016 - sleep.theclinics.com
Obstructive sleep apnea (OSA) is increasingly recognized as an important modifiable risk
factor for cardiovascular disease (CVD). The prevalence of OSA in the United States is …

Cheyne-Stokes Respiration in Chronic Heart Failure–Treatment With Adaptive Servoventilation Therapy–

O Oldenburg - Circulation Journal, 2012 - jstage.jst.go.jp
2306 OLDENBURG O hypopnea index (AHI) describes the number of classified respiratory
events per hour of sleep. Besides these clear differences in apnea type, CSA with CSR is …

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea

H Fox, O Oldenburg, S Javaheri, P Ponikowski… - Sleep, 2019 - academic.oup.com
Abstract Study Objective To evaluate long-term efficacy and safety of phrenic nerve
stimulation (PNS) in patients with moderate-to-severe central sleep apnea (CSA) through 3 …

Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients

R Khayat, R Small, L Rathman, S Krueger… - Journal of cardiac …, 2013 - Elsevier
Sleep-disordered breathing (SDB) is the most common comorbidity in patients with heart
failure (HF) and has a significant impact on quality of life, morbidity, and mortality. A number …

Long‐term experience with first‐generation implantable neurostimulation device in central sleep apnea treatment

H Fox, T Bitter, D Horstkotte… - Pacing and Clinical …, 2017 - Wiley Online Library
Background Sleep‐disordered breathing (SDB) and Cheyne‐Stokes respiration (CSR) are
associated with shorter survival in patients with heart failure. A novel treatment method for …

[HTML][HTML] Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea

N Ding, X Zhang - Journal of Thoracic Disease, 2018 - ncbi.nlm.nih.gov
Central sleep apnea (CSA) is common in heart failure (HF) patients. Traditional treatment of
CSA, including continuous positive airway pressure (CPAP), adaptive servo ventilation …

Interventional techniques to increase implantation success of transvenous phrenic nerve stimulation for central sleep apnea treatment

KJ Gutleben, H Fox, P Sommer, V Rudolph… - Sleep and Breathing, 2020 - Springer
Purpose Central sleep apnea (CSA) is a highly common comorbidity in heart failure (HF)
patients and is known to deteriorate quality of life and prognosis. Effective treatment options …

A novel therapeutic approach for central sleep apnea: Phrenic nerve stimulation by the remedē® System

S Joseph, MR Costanzo - International Journal of Cardiology, 2016 - Elsevier
Central sleep apnea is a devastating disease which occurs in approximately 40% of patients
with heart failure as well as patients with a history of stroke, opioid use and neurological …

[HTML][HTML] Синдром апноэ во сне и кардиологическая патология: современный взгляд

ИГ Гордеев, ОЮ Шайдюк… - Российский …, 2012 - cyberleninka.ru
Обзор посвящён современным данным исследований взаимосвязи синдрома апноэ во
время сна и поражений сердечно-сосудистой системы. Рассматриваются различные …

神经肌肉电刺激在慢性阻塞性肺疾病急性加重早期肺康复的应用

李晓聪, 徐远达 - 国际呼吸杂志, 2014 - cqvip.com
COPD 是我国常见的呼吸系统疾病, 常伴有骨骼肌功能异常等全身反应. 神经肌肉电刺激是肺
康复锻炼治疗的一种手段, 已经在小范围内应用于COPD 急性加重患者早期的康复治疗 …